Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

  1. Shuhei Nakanishi, MD,
  2. Kiminori Yamane, MD,
  3. Nozomu Kamei, MD,
  4. Masamichi Okubo, MD and
  5. Nobuoki Kohno, MD
  1. From the Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
  1. Address correspondence and reprint requests to Dr. Shuhei Nakanishi, Radiation Effects Research Foundation, 5-2 Hijiyama Park, Minami-ku, Hiroshima 732-0815, Japan. E-mail: nshuhei{at}rerf.or.jp
Diabetes Care 2003 Oct; 26(10): 2754-2757. https://doi.org/10.2337/diacare.26.10.2754
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE—Increasing evidence from a cohort of Caucasians recently suggests that an elevated level of C-reactive protein (CRP) is associated with an increased risk of developing type 2 diabetes. However, Japanese subjects are skewed to lower CRP concentrations than westerners. Therefore, the effect of CRP on the development of type 2 diabetes among Japanese is unclear.

RESEARCH DESIGN AND METHODS—We examined 396 male and 551 female nondiabetic Japanese Americans who underwent a 75-g oral glucose tolerance test (GTT) and were then followed for an average of 6.5 years. We investigated whether elevated serum CRP level is a risk factor in the development of type 2 diabetes among these subjects.

RESULTS—Subjects with a high CRP level showed a significantly higher incidence of type 2 diabetes compared with subjects with a low level among both men (P = 0.028) and women (P = 0.004) in a log-rank test. In a Cox proportional hazards model dividing quartiles of CRP, the hazard ratios for diabetes development in the highest versus lowest quartile of CRP levels were 2.84 (95% CI 1.09–7.39) among men and 3.11 (1.25–7.75) among women after adjustment for age, smoking, family history of diabetes, classification of a 75-g GTT, hormone replacement therapy (among women), BMI, and homeostasis model assessment.

CONCLUSIONS—Among Japanese Americans, CRP may be a risk factor for development of type 2 diabetes independent of either obesity or insulin resistance. Our results suggest that inflammation may be closely related to the mechanism of type 2 diabetes among Japanese Americans.

  • CRP, C-reactive protein
  • FH, family history
  • GTT, glucose tolerance test
  • HOMA, homeostasis model assessment
  • HRT, hormone replacement therapy

Complications of diabetes reduce patients’ quality of life. Therefore, it is necessary to identify individuals with glucose intolerance as early as possible to prevent its progression into diabetes. Thus, it may be more efficient to intervene when high-risk factors in subjects can be readily identified.

C-reactive protein (CRP) is a marker of acute inflammation and is generally used as a measure of inflammatory disease. Recently, CRP increases have been reported in obesity (1,2) and type 2 diabetes (1). Thus, there is increasing evidence to suggest that insulin resistance is a chronic low-grade inflammatory state (3). In prospective case-control studies (4–9), elevated levels of CRP predict the development of type 2 diabetes, supporting a possible role for inflammation in diabetogenesis (4,6–8).

According to the literature on Japanese populations (10), Japanese subjects are skewed to lower CRP concentrations than westerners. Therefore, the acute-phase response may vary due to racial differences. However, there have been no published reports investigating the relationship between CRP and the development of type 2 diabetes among Japanese.

Although Americans of Japanese descent share a virtually identical genetic makeup with native Japanese currently living in Japan, Japanese Americans have approximately twice the incidence of type 2 diabetes compared with Japanese living in Japan, primarily because of a westernized lifestyle (11). We compared those groups that developed diabetes during the long follow-up period with those that did not develop the disease to investigate the role of CRP in diabetes in men and women.

RESEARCH DESIGN AND METHODS

Study subjects were Japanese Americans enrolled in medical surveys conducted from 1988 to 2000 in Hawaii and Los Angeles, California. Subjects were free of infectious symptoms, autoimmune disease, or any other acute conditions as assessed by medical interview. The surveys have been previously described in detail elsewhere (11–13). The study population consisted of 396 men and 551 women who did not have diabetes, as ascertained by a 75-g glucose tolerance test (GTT) at baseline. Among all repeating participants, 43.6% were examined twice, 24.2% three times, 17.3% four times, 14.8% five times, and 0.1% six times. Family history (FH) of type 2 diabetes, use of hormone replacement therapy (HRT) for women, and smoking status were assessed using standard interviewing procedures. The relationship between CRP and the development of diabetes during the follow-up period was analyzed. During each follow-up examination, participants who were free of diabetes at baseline had a 75-g GTT performed after an overnight fast. Incident diabetes was diagnosed as fasting glucose of ≥7 mmol/l or 2-h glucose of ≥11.1 mmol/l (14). Blood was centrifuged, and the obtained serum was immediately frozen at −80°C. Serum samples were subsequently brought back to Japan. Insulin was measured by double-antibody radioimmunoassay. CRP was measured using latex-enhanced immunonephelometric assays (15) on a BNII analyzer (Dade Behring, Tokyo, Japan). Insulin resistance was evaluated with homeostasis model assessment (HOMA) (16). This study was approved by the ethics committee of the Hiroshima University and the Council of the Hiroshima Kenjin-Kai Association in Hawaii and Los Angeles.

In this study, data on men and women aged 20–93 years were analyzed independently. Results were expressed as the means ± SEM. Because triglycerides, HOMA, and BMI did not show normal distributions, the data were analyzed after logarithmic transformation. Baseline CRP concentration was divided at the 50th percentile of the sex-specific distributions (>0.68 mg/l for men and >0.76 mg/l for women), and relationships between CRP and the development of diabetes were evaluated using Kaplan-Meier plots and log-rank tests. To test the significance of CRP as a predictor of incidence of type 2 diabetes, CRP concentration was divided into quartiles based on its population (among men, <0.39, 0.39–0.67, 0.68–1.43, and ≥1.44 mg/l; among women, <0.37, 0.37–0.75, 0.76–1.66, and ≥1.67 mg/l); quartile specific hazard ratios were estimated through a Cox proportional hazards model. The numbers of the subjects were 99, 98, 99, and 100, respectively, among men; the numbers were 138, 138, 137, and 138, respectively, among women. The development of diabetes was designated the dependent variable (1, developed diabetes; 0, did not develop diabetes), whereas age, smoking status, FH (1, positive; 0, negative), classification of a 75-g GTT (1, impaired glucose tolerance; 0, normal glucose tolerance), HRT for women, BMI, and HOMA were used as independent variables in addition to CRP quartiles. For proportional hazards, assumption was checked with a graphical plot of logSt versus logt for the variables included in the model (S denoted the survival function, and t denoted time) and found to be acceptable. For all analyses, SAS package version 8.2 (SAS, Cary, NC) was used.

RESULTS

In this study, the distribution of serum CRP was skewed to low levels. A total of 57 of 396 men and 65 of 551 women developed diabetes during the follow-up period (6.54 ± 0.10 years). We subsequently investigated the rate of development of the disease according to dichotomized CRP levels. Among men with a high CRP level, 36 of 199 were diagnosed with type 2 diabetes. Among men with a low CRP level, 21 of 197 were diagnosed with the disease. Among women with a high CRP level, 43 of 275 were diagnosed with type 2 diabetes. Among women with a low CRP level, 22 of 276 were diagnosed with the disease. We observed significant differences in rates of incidence between subjects with a high versus low CRP level in both sexes because Kaplan-Meier curves and log-rank tests (P = 0.028 for men; P = 0.004 for women) were statistically significant.

In a Cox proportional hazards model including quartiles of CRP, the hazard ratios for developing diabetes by increasing quartiles of CRP were 1.0, 1.99 (95% CI 0.73–5.41), 2.24 (0.83–6.03), and 2.84 (1.09–7.39) among men, respectively (P = 0.035 for trend), and the hazard ratios for increasing quartiles of CRP were 1.0, 2.22 (0.86–5.74), 2.55 (1.00–6.49), and 3.11 (1.25–7.75) among women, respectively (P = 0.036 for trend) adjusted for age, smoking status, FH, classification of a 75-g GTT, HRT for women, BMI, and HOMA (Fig. 1). The adjusted hazard ratio per unit of CRP was 1.00 (1.00–1.001) among all participants, with the same ratio observed among both men and women. The adjusted hazard ratios per unit log (CRP) were 1.22 (1.03–1.45) among all participants, 1.14 (0.89–1.45) among men, and 1.40 (1.09–1.80) among women.

CONCLUSIONS

Although the influence of CRP on the development of type 2 diabetes in Japanese populations has not been demonstrated, this study did show that a relationship exists between CRP and the development of type 2 diabetes in Japanese Americans, as well as other races (4,6–8), which is a population thought to be genetically identical to native Japanese populations.

CRP levels followed in this study have been shown to be the same (2,17) or lower (1,4,7,9,18) in Japanese-Americans compared with Caucasians. However, they were elevated compared with those of native Japanese populations (10,19). From an early age, Japanese Americans have lived in a highly westernized environment, with features such as a high-fat diet, for a longer period of time and more intensely when compared with native Japanese (12), resulting in greater insulin resistance. Elevated proinflammatory mediators, such as tumor necrosis factor-α, subsequent to exposure to a high-fat diet (20) might result in a low-grade inflammatory state (21). This might be one explanation of the relationship between CRP and the westernized lifestyle among Japanese Americans.

CRP is thought to be produced in the liver (2) and stimulated by tumor necrosis factor-α, which is itself derived from adipose tissue (22) and predominantly induced by interleukin-6 (23). Accordingly, the possibility exists that CRP is an indirect indicator of insulin resistance via obesity. In this study, the high CRP group manifested the characteristic so-called metabolic syndrome, which is namely a tendency toward elevated blood glucose, insulin, BMI, and triglycerides and decreased HDL cholesterol levels (data not shown). However, in both sexes, the highest quartile group was at significantly higher risk for developing diabetes compared with the lowest quartile group after adjustment for BMI and HOMA. Additionally, the hazard proportion trend was observed as quartiles increased (Fig. 1). Therefore, the low-grade inflammatory state illustrated by CRP increase was considered a risk factor independent of obesity or insulin resistance, which might suggest an unknown mediator involved in the development of diabetes.

The mechanisms of correlation between CRP and the development of diabetes are unclear. However, there are several possible explanations. One of them is the oxidative stress generated hyperglycemia (24). Oxidative stress might be implicated in promoting a state of low-grade inflammation indicated by markers such as CRP with elderly type 2 diabetes (25). On the other hand, oxidative stress was thought to impair insulin endocytosis in endotherial cell lines (26), and it could precede the development of the endotherial dysfunction and insulin resistance (27). This points to the possibility that CRP may be involved in the development of diabetes.

We also have to consider the genetic factors of CRP. Recently, among nonsmoking healthy adult women, FH is thought to be associated with increased plasma CRP levels (28); although in this study, there was no relationship between FH and CRP in either sex. It is hypothesized that there may be a genetic relationship between CRP and diabetes, even though it is unclear whether a common genetic factor really exists. To understand the relationship between CRP and type 2 diabetes, further study is needed.

Several limitations of this study remained. First, anti-inflammatory medication might not have been considered completely in this study, although subjects were free of inflammatory diseases. Second, the definitions of inflammatory diseases tend to be transitional. Accordingly, whether the subjects were excluded by exactly the same criteria is uncertain.

CRP levels in nondiabetic Japanese Americans were slightly lower compared with Caucasians but higher than those in native Japanese populations. This suggests that westernization of lifestyle may cause a high CRP level. This report demonstrated that among Japanese Americans, CRP is considered a risk factor for diabetes independent of obesity or insulin resistance. It is suggested that the mechanism of diabetes development may be related to inflammation.

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

Adjusted hazard ratio of type 2 diabetes from a Cox proportional hazards model according to baseline serum CRP concentrations. Data were expressed after adjustment of age, smoking status, FH, classification of 75-g GTT, HRT use for women, BMI, and HOMA. Error bars indicate 95% CI. Trend analysis was P = 0.035 among men and P = 0.036 among women. *P < 0.05 compared with the lowest quartile of each sex.

Acknowledgments

The authors thank the members of the Hiroshima Kenjin-Kai of Hawaii and Southern California for their participation. We are indebted to the late Dr. S. Takashina, former President of Hiroshima General Hospital and J. Suita, Dade Behring, for the assay of samples.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted July 9, 2003.
    • Received April 22, 2003.
  • DIABETES CARE

References

  1. ↵
    Ford ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971–1977, 1999
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Hak AE, Stehouwer DA, Bots ML, Polderman KH, Schalkwijk CG, Westerndorp ICD, Hofman A, Witterman CM: Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Atheroscler Thromb Vasc Biol 19:1986–1991, 1999
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Bell DS: Inflammation, insulin resistance, infection, diabetes, and atherosclerosis. Endocr Pract 6:272–276, 2000
    OpenUrlPubMed
  4. ↵
    Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 18:327–334, 2001
    OpenUrl
  5. Festa A, D’Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. Diabetes 51:1131–1137, 2002
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP: The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384–2389, 2001
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM: Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016–2021, 2002
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O’Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West Scotland Coronary Prevention Study. Diabetes 51:1596–1600, 2002
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, Koenig W: C-reactive protein as a predictor for incident diabetes mellitus among middle aged men: results from the MONICA Augsburg Cohort Study, 1984–1998. Arch Intern Med163:93–99, 2003
  10. ↵
    Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E: Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population. Am J Epidemiol 153:1183–1190, 2001
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Hara H, Egusa G, Yamakido M: Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles. Diabet Med 13:S133–S142, 1996
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Watanabe H, Yamane K, Fujikawa R, Okubo M, Egusa G, Kohno N: Westernization of lifestyle markedly increase carotid intima-media wall thickness (IMT) in Japanese people. Atherosclerosis 166:67–72, 2003
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Egusa G, Murakami F, Ito C, Matsumoto Y, Kado S, Okamura M, Mori H, Yamane K, Hara H, Yamakido M: Westernized food habits and concentrations of serum lipids in the Japanese. Atherosclerosis 100:249–255, 1993
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197, 1997
    OpenUrlFREE Full Text
  15. ↵
    Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45: 2136–2141, 1999
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Matthews DR, Hosker JP, Rundenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Ridker PM, Cushman M, Stampfer JS, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979, 1997
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB: Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349:462–466, 1997
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M: C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 104:63–67, 2001
    OpenUrlAbstract/FREE Full Text
  20. ↵
    James MJ, Gibson RJ, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Nutr 71:343S–348S, 2000
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Fernandez-Real JM, Ricart W: Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367–1374, 1999
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Warren RS, Starnes HF Jr, Gabrilove JL, Oettgen HF, Brennan MF: The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 122:1396–1400, 1987
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 265:621–636, 1990
    OpenUrlFREE Full Text
  24. ↵
    Nishikawa T, Edelstein D, Du XL, Yamaguchi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404:787–790, 2000
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Arnalich F, Hernanz A, López-Maderuelo D, Peòa JM, Camacho J, Madero R, Vázquez JJ, Montiel C: Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res 32:407–412, 2000
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    Bertelsen M, Änggård EE, Carrier MJ: Oxidative stress impairs insulin internalization in endotherial cells in vitro. Diabetologia 44:605–613, 2001
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Gopaul NK, Manraj MD, Hébé A, Lee Kwai Yan S, Johnston A, Carrier MJ, Änggård EE: Oxidative stress could precede endotherial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44:706–712, 2001
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Pannacciulli N, De Pergola G, Giorgino F, Giorgino R: A family history of type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women. Diabet Med 19:689–692, 2002
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 26 (10)

In this Issue

October 2003, 26(10)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans
Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei, Masamichi Okubo, Nobuoki Kohno
Diabetes Care Oct 2003, 26 (10) 2754-2757; DOI: 10.2337/diacare.26.10.2754

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans
Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei, Masamichi Okubo, Nobuoki Kohno
Diabetes Care Oct 2003, 26 (10) 2754-2757; DOI: 10.2337/diacare.26.10.2754
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Diabetic Retinopathy and the Risk of Coronary Heart Disease
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.